Moderately to Severely Active Rheumatoid Arthritis
1 competing product in clinical development for Moderately to Severely Active Rheumatoid Arthritis.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CT-P13 SC Auto-Injector + Placebo Auto-Injector | Celltrion | Phase 3 | Active | 77 |